HopeStage
Back to all studies
CompletedNCT04817410

Starting oral naltrexone in the emergency department for alcohol use

About this titleRead the official source — NCT04817410
Medication studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: September 28, 2021
Recruitment status
Completed
Enrollment listed in the registry
30
Sponsor
Icahn School of Medicine at Mount Sinai
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT04817410
Official title
Show the full official title

Emergency Department Initiated Oral Naltrexone for Patients With Moderate to Severe Alcohol Use Disorder: A Pilot Feasibility Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Icahn School of Medicine at Mount Sinai, a university.

Did this study involve medication?

Yes. The study involved medication, including Emergency Department Initiated Oral Naltrexone.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies